BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7829527)

  • 1. Wild type p53 stimulates expression from the human multidrug resistance promoter in a p53-negative cell line.
    Goldsmith ME; Gudas JM; Schneider E; Cowan KH
    J Biol Chem; 1995 Jan; 270(4):1894-8. PubMed ID: 7829527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of 5' and 3' sequences involved in the regulation of transcription of the human mdr1 gene in vivo.
    Madden MJ; Morrow CS; Nakagawa M; Goldsmith ME; Fairchild CR; Cowan KH
    J Biol Chem; 1993 Apr; 268(11):8290-7. PubMed ID: 8096520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversible transcriptional activation of mdr1 by sodium butyrate treatment of human colon cancer cells.
    Morrow CS; Nakagawa M; Goldsmith ME; Madden MJ; Cowan KH
    J Biol Chem; 1994 Apr; 269(14):10739-46. PubMed ID: 7908296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of transcription functions of the p53 tumor suppressor by the mdm-2 oncogene.
    Chen J; Lin J; Levine AJ
    Mol Med; 1995 Jan; 1(2):142-52. PubMed ID: 8529093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional suppression of multidrug resistance-associated protein (MRP) gene expression by wild-type p53.
    Wang Q; Beck WT
    Cancer Res; 1998 Dec; 58(24):5762-9. PubMed ID: 9865734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cloning and initial analysis of the human multidrug resistance-related MVP/LRP gene promoter.
    Lange C; Walther W; Schwabe H; Stein U
    Biochem Biophys Res Commun; 2000 Nov; 278(1):125-33. PubMed ID: 11071864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The region 3' to the major transcriptional start site of the MDR1 downstream promoter mediates activation by a subset of mutant P53 proteins.
    Strauss BE; Haas M
    Biochem Biophys Res Commun; 1995 Dec; 217(1):333-40. PubMed ID: 8526930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene.
    Miyashita T; Reed JC
    Cell; 1995 Jan; 80(2):293-9. PubMed ID: 7834749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Y-box consensus sequence is required for basal expression of the human multidrug resistance (mdr1) gene.
    Goldsmith ME; Madden MJ; Morrow CS; Cowan KH
    J Biol Chem; 1993 Mar; 268(8):5856-60. PubMed ID: 8095499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wild-type murine p53 represses transcription from the murine c-myc promoter in a human glial cell line.
    Moberg KH; Tyndall WA; Hall DJ
    J Cell Biochem; 1992 Jun; 49(2):208-15. PubMed ID: 1400626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The MDR1 downstream promoter contains sequence-specific binding sites for wild-type p53.
    Strauss BE; Shivakumar C; Deb SP; Deb S; Haas M
    Biochem Biophys Res Commun; 1995 Dec; 217(3):825-31. PubMed ID: 8554604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of cellular and viral promoters by mutant human p53 proteins found in tumor cells.
    Deb S; Jackson CT; Subler MA; Martin DW
    J Virol; 1992 Oct; 66(10):6164-70. PubMed ID: 1356162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation of polyomavirus DNA replication by wild-type p53 through the DNA-binding site.
    Kanda T; Segawa K; Ohuchi N; Mori S; Ito Y
    Mol Cell Biol; 1994 Apr; 14(4):2651-63. PubMed ID: 8139565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53 involvement in activation of the cytokeratin 8 gene in tumor cell lines.
    Mukhopadhyay T; Roth JA
    Anticancer Res; 1996; 16(1):105-12. PubMed ID: 8615594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the human immunodeficiency virus type 1 long terminal repeat by transforming mutants of human p53.
    Subler MA; Martin DW; Deb S
    J Virol; 1994 Jan; 68(1):103-10. PubMed ID: 8254719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.
    Perego P; Giarola M; Righetti SC; Supino R; Caserini C; Delia D; Pierotti MA; Miyashita T; Reed JC; Zunino F
    Cancer Res; 1996 Feb; 56(3):556-62. PubMed ID: 8564971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transactivation of the human multidrug resistance (MDR1) gene promoter by p53 mutants.
    Nguyen KT; Liu B; Ueda K; Gottesman MM; Pastan I; Chin KV
    Oncol Res; 1994; 6(2):71-7. PubMed ID: 7949467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of exogenous ras and p53 on P-glycoprotein function in immortalized rodent fibroblasts.
    Kopnin BP; Stromskaya TP; Kondratov RV; Ossovskaya VS; Pugacheva EN; Rybalkina EY; Khokhlova OA; Chumakov PM
    Oncol Res; 1995; 7(6):299-306. PubMed ID: 8527864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The core promoter region of the P-glycoprotein gene is sufficient to confer differential responsiveness to wild-type and mutant p53.
    Zastawny RL; Salvino R; Chen J; Benchimol S; Ling V
    Oncogene; 1993 Jun; 8(6):1529-35. PubMed ID: 8502478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-efficiency gene transfer and high-level expression of wild-type p53 in human lung cancer cells mediated by recombinant adenovirus.
    Zhang WW; Fang X; Mazur W; French BA; Georges RN; Roth JA
    Cancer Gene Ther; 1994 Mar; 1(1):5-13. PubMed ID: 7621238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.